
π Detect, Diagnose, Defend: Protecting the Heart During ICI Therapy per IC-OS π«π§π‘οΈ
Dr RR Baliga's "Got Knowledge Doc" Podkast
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
π Immune checkpoint inhibitors have transformed cancer careβbut they come with a cardiovascular shadow.
A new International Cardio-Oncology Society (IC-OS) position statement offers the clearest guidance yet on myocarditis, pericarditis, arrhythmias, ACS, and noninflammatory HF linked to ICI therapy. π«π‘
Key insights include:
β’ Early recognition with troponin, ECG, and CMR π§ͺπ
β’ Smoldering vs. nonsevere vs. fulminant myocarditis distinctions π
β’ Steroid-first management and the evolving role of abatacept + JAK inhibitors π
β’ Nuanced approaches to ICI rechallenge when cancer control demands it ππ―
β’ The essential role of multidisciplinary cardio-oncology teams π€
This is a must-read for anyone navigating the intersection of oncology, cardiology, and immunotherapy. ππ₯